CellaVision AB (CLVSF)
15.85
0.00 (0.00%)
USD |
OTCM |
Feb 20, 16:00
CellaVision EPS Diluted (Quarterly) : 0.1899 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Orexo AB | -- |
| BioInvent International AB | -0.2063 |
| Hansa Biopharma AB | -0.1724 |
| BioArctic AB | -0.0106 |
| Camurus AB | 0.1778 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.53M |
| Revenue (Quarterly) | 20.96M |
| Total Expenses (Quarterly) | 16.43M |
| Enterprise Value | 360.41M |
| Gross Profit Margin (Quarterly) | 66.83% |
| Profit Margin (Quarterly) | 21.61% |
| Earnings Yield | 4.13% |
| Operating Earnings Yield | 5.44% |
| Normalized Earnings Yield | 4.128 |